St. Mary Neuroscience Institute
The St. Mary Neuroscience Institute is one of the most comprehensive neurosurgical and neurological programs in the Greater Philadelphia region. Our neurosurgeons offer a full range of conventional and minimally invasive treatment options for diseases and conditions of the brain and spine.
Specialty surgical services
Hybrid OR equipped with biplane imaging technology
Our neurosurgeons perform lifesaving minimally invasive endovascular procedures in a hybrid operating room. The hybrid OR is an advanced surgical suite equipped with specialized “biplane” imaging technology that enables our team to treat high-risk patients who need immediate surgical intervention. The biplane imaging system delivers detailed, high-quality, 3D X-ray images during the surgical procedure.
Together, the hybrid OR and biplane technology allow our surgeons to treat conditions such as stroke, aneurysm, brain tumors and arteriovenous malformation (AVM).
Neuro ICU
A Neurologic Intensive Care Unit is a dedicated critical care space for patients with life-threatening neurological conditions or who are recovering post-operatively from a neurosurgical procedure. The St. Mary Neuroscience Institute’s Neuro ICU is staffed 24/7 with a critical care team specially trained in the treatment of patients with severe brain injuries or conditions.
Conditions we treat
Our neurosurgeons perform lifesaving procedures to treat a wide range of conditions, including:
- Aneurysms
- Arteriovenous malformations (AVM)
- Brain, pituitary, skull base and spine tumors
- Chiari malformation
- Concussion
- Normal pressure hydrocephalus (NPH)
- Parkinson’s Disease and movement disorders
- Spinal stenosis
- Spondylosis
- Stroke
Certifications and accreditations
St. Mary Medical Center is certified as a Primary Stroke Center by The Joint Commission. In addition, the hospital has earned the American Stroke Association’s Get With The Guidelines® Gold Plus Performance Award for Stroke, and is a Target: Stroke Honor Roll recipient for meeting stroke quality measures for treatment with the clot-busting drug tPA.